National Institutes of Health government contracts, bids & RFPs
State / local / other government buyer · 376 open bids
Open government contracts, bids and RFPs from National Institutes of Health, the vendors it awards most, and the industries it buys — aggregated from public procurement data and updated daily.
Paste your website — we'll show the open government contracts that fit your business.
Free · no signup · we read your homepage once. We don't store your email.
National Institutes of Health contract activity
A current snapshot based on 20 of 376 open listings shown on this page. Counts update with the directory.
- Federal Grants (Grants.gov)20
Deadline outlook
- Next 30 days
- 20
- Later
- 0
- Open / rolling
- 0
Most represented buyers
- United States20
3 of the listings shown were posted in the last 30 days. Federal Grants (Grants.gov) contributes the largest share (20). United States is the most represented buyer in this snapshot.
Open opportunities
- Due Oct 30, 2026Posted Jun 18, 2026
- Due Oct 30, 2026Posted Jun 18, 2026
- Due Oct 30, 2026Posted Jun 18, 2026
- Due Oct 30, 2026Posted Sep 28, 2026
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)United States
This Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required) PAR, a re-issue of PAR-24-035, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplify Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same.…
MoreDue Nov 2, 2026Posted Dec 9, 2024 - Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)United States
This Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed) PAR, was re-issued as a result of the Simplifying Review of Research Project Grant Applications [link: https://grants.nih.gov/policy-and-compliance/policy-topics/peer-review/simplifying-review]. The Simplified Review changes in Section V are the only changes that have been made. All other aspects of this funding opportunity remain the same. Eligibility: Other Eligible…
MoreDue Nov 2, 2026Posted Dec 9, 2024 - Due Nov 5, 2026Posted Nov 15, 2024
- Due Nov 6, 2026Posted Nov 18, 2024
- Due Nov 6, 2026Posted Aug 31, 2026
- Due Nov 9, 2026Posted Aug 31, 2026
- Due Nov 9, 2026Posted Aug 31, 2026
- Due Nov 10, 2026Posted Jun 3, 2026
- Due Nov 10, 2026Posted Jun 3, 2026
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)United States
The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for the conduct of scientific research utilizing data from expanded access (EA) for investigational drugs or biological products as described in section 561 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb). These applications will target intermediate size populations of patients living with amyotrophic lateral sclerosis (ALS) who are not eligible for ongoing clinical trials for the prevention,…
MoreDue Nov 10, 2026Posted May 4, 2026 - Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)United States
The purpose of this notice of funding opportunity (NOFO) is to solicit applications for an Infectious Diseases Clinical Trials Network (IDCTN). The IDCTN, comprised of the Clinical Trial Evaluation Units (CTEUs) and a Network Coordination Center (NCC), supports the evaluation of interventions for emerging and chronic infections. The CTEUs design and implement clinical trials and studies, while the NCC provides the administrative and operational framework for a collaborative, integrated network…
MoreDue Nov 10, 2026Posted Sep 1, 2026 - Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)United States
This Notice of Funding Opportunity (NOFO) invites applications proposing a Data Coordinating Center that integrates and disseminates multiscale mouse brain datasets for the aging and Alzheimer's disease (AD) research community. The Data Coordinating Center will establish the Aging and AD Mouse Brain Atlas (AD-MBA), which will serve as a central, unified research resource for multi-omic and connectomic mouse brain datasets emerging from the NIA AD Multimodal Atlas Projects (AD-MAPs). The Data…
MoreDue Nov 10, 2026Posted Sep 1, 2026 - Pilot Projects to Enhance the Human Virome Program (R03 Clinical Trials Not Allowed)United States
The Common Fund Human Virome Program (HVP) aims to extensively and comprehensively characterize the "healthy" human virome (the collection of viruses that normally reside inside the human body without evidence of disease) and create tools, models, and methods that will enable an in-depth study of its variation and composition in relation to host factors and its influence on health and disease. The purpose of this NOFO is to support small pilot projects that extend the goals of the HVP,…
MoreDue Nov 10, 2026Posted Oct 8, 2026 - Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)United States
The purpose of this notice of funding opportunity (NOFO) is to support a Clinical Research Network (CRN) on Antimicrobial Resistance (AMR). The program aims to design, implement, and manage clinical research that addresses pivotal clinical questions related to AMR through a coordinated and integrated CRN. The CRN will comprise four centers: the Scientific Leadership Center (SLC), the Clinical Operations Center (COC), the Laboratory Center (LC), and the Statistics and Data Coordination Center…
MoreDue Nov 10, 2026Posted Sep 1, 2026 - Limited Competition: NIH Research Evaluation and Commercialization Hubs (REACH) (SB0 Clinical Trial Optional)United States
This Notice of Funding Opportunity (NOFO) announces the renewal of the NIH Research Evaluation and Commercialization Hub (REACH) program, established to facilitate and accelerate the translation of academic biomedical discoveries into products that improve patient care and public health. Through this program, NIH will provide the qualifying institutions with the funds to seed the creation of academic entrepreneurship Hubs. Hubs will be responsible for providing innovators with both the initial…
MoreDue Nov 10, 2026Posted Sep 24, 2026 - Due Nov 13, 2026Posted Jan 3, 2024
Showing 20 of 376 open bids.
How to win National Institutes of Health contracts
- Register as a vendor on National Institutes of Health's procurement portal.
- Match your NAICS / commodity codes to what it buys (see the top codes above).
- Ask about local small-business and vendor-preference programs — see set-asides explained.
- Monitor its open bids above, or set a GovBidAlerts alert.
New to government contracting? Start with our GovCon guides and glossary.